Bioline Reports 14030083

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

SID No : 14030083 Patient ID : 1400182211

Branch : TAMBARAM

Mr. BALAMURUGAN S
Age / Sex : 41 Y 2 M / Male Collected Date : 06/08/2023 / 10:37

Ref. By : Dr. PADMA V MD (GEN MEDICINE) D.DIAB., Received Date : 06/08/2023 / 15:24
FRCP DR.PADMA'S DIABETES & MEDICAL
CLINIC
Reported Date : 06/08/2023 / 16:48

Final Test Report Page 1 of 5

Specimen Test Name Result Units Reference Range / Method


BIOCHEMISTRY

Microalbumin

Urine Microalbumin 43.9 mg/L . (Immunoturbidimetry)

Urine Creatinine 320.1 mg/dL Male


<40 yrs : 24 - 392
>=40yrs : 22 - 328
Female
<40 yrs : 16 - 327
>=40yrs : 15 - 278 (Colorimetric
: Alkaline picrate)

Urine Microalbumin/Creatinine 13.71 mg Alb/g Non exercised state


Creat Adults : <20
Children (3-5 yrs): <37
(Calculated)
Note: To detect early kidney disease in those with diabetes or other risk factors such as hypertension, heart failure, cirrhosis, or systemic lupus
erythematosus (SLE). According to the American Diabetes Association and National Kidney Foundation, those with type 1 diabetes should get tested
starting 5 years after onset of the disease and then annually, and with type 2 diabetes should get tested starting at the time of diagnosis and then
annually. Patients with hypertension may be tested at regular intervals, with the frequency determined by their healthcare practitioner. Persistent
increased protein in the urine (two positive tests over 3 - 6 months) is the principal marker of kidney damage, acting as an early and sensitive marker in
many types of kidney disease.

Verified By Dr.G.Kavitha MD.,


Dr.B.Santhoshkumar Consultant Biochemist
SID No : 14030083 Patient ID : 1400182211
Branch : TAMBARAM

Mr. BALAMURUGAN S
Age / Sex : 41 Y 2 M / Male Collected Date : 06/08/2023 / 10:24

Ref. By : Dr. PADMA V MD (GEN MEDICINE) D.DIAB., Received Date : 06/08/2023 / 12:46
FRCP DR.PADMA'S DIABETES & MEDICAL
CLINIC
Reported Date : 06/08/2023 / 16:48

Final Test Report Page 2 of 5

Specimen Test Name Result Units Reference Range / Method


Fluoride Glucose, Fasting 124.5 mg/dL Healthy Adult or children : less
than 100
Pre diabetic : 100 – 125
Diabetic : 126 or above
(ADA 2019) (Hexokinase)

Fluoride Glucose, Post-prandial 220.4 mg/dL Healthy : <140


Pre diabetic : 140-199
Diabetic : >=200
(ADA-2019) (Hexokinase)
Blood glucose level primarily depends upon individual characters like type and quantity of food intake, physical activity and the body’s metabolic response. Lower
postprandial blood glucose level than fasting level can be noticed in variety of conditions in both normal population and diabetics. Various modifiable factors along with
underlying condition of patient that affect blood glucose levels are:
1. Pre-analytical factors such as smoking, caffeinated drinks, use of hypoglycemic drugs, heavy exercise, anxiety, strenuous activity before sampling & time of sample
collection. 2.Change in glucagon to insulin ratio, the commonest cause of impaired fasting glucose tolerance and diabetes mellitus. 3. high carbohydrate meal at
bedtime or not enough diabetic medication, disturbed sleep, and other lesser known entities like Dawn phenomenon and Somogyi effect. 4.Chewing and eating slower
or gastroparesis can reduce the reactive glucose surge post meal. 5.Consumption of less or eat non-carbohydrate meal before testing for PPBG level.
Due to individual variation of FBG and PPBG and large imprecision in analysis, researchers have advocated the use of HbA1c only for diabetes diagnosis.

HbA1c

EDTA BLOOD Glycosylated Haemoglobin 7.3 % <8 - Less Stringent Goal


(HbA1c) <7 - General Goal
< 6.5 - More Stringent Goal
< 5.7 - Non-Diabetic Level
(HPLC)

EDTA BLOOD Estimated Average Glucose 162.8 mg/dL (Calculation)


(eAG)

Verified By Dr.G.Kavitha MD.,


Dr.B.Santhoshkumar Consultant Biochemist
SID No : 14030083 Patient ID : 1400182211
Branch : TAMBARAM

Mr. BALAMURUGAN S
Age / Sex : 41 Y 2 M / Male Collected Date : 06/08/2023 / 10:24

Ref. By : Dr. PADMA V MD (GEN MEDICINE) D.DIAB., Received Date : 06/08/2023 / 12:49
FRCP DR.PADMA'S DIABETES & MEDICAL
CLINIC
Reported Date : 06/08/2023 / 16:48

Final Test Report Page 3 of 5

Specimen Test Name Result Units Reference Range / Method


Serum Creatinine. 0.92 mg/dL 0.90 - 1.30 (Jaffe)

Serum Uric Acid. 3.70 mg/dL 3.50 - 7.20 (Enzymatic-


Colorimetric)
Lipid Profile

Serum Cholesterol, Total 123.6 mg/dL Adult (NCEP ATP-III)


Desirable : <200
Borderline high : 200 - 239
High : >239 (Enzymatic :
CHOD-PAP)

Note: Above Biological interval is based on 9 to 12 hours fasting.

Serum Triglycerides 69.50 mg/dL Adult (NCEP ATP-III)


Normal : <150
High : 150 - 199
Hypertriclyceridemic: 200 - 499
Very High : >499 (Enzymatic
Colorimetric : GPO-PAP)

Note: Above Biological interval is based on 9 to 12 hours fasting

Serum Cholesterol, HDL 41.5 mg/dL Adult (NCEP ATP-III)


Low : < 40
High : >=60 (Enzymatic-
Colorimetric)

Verified By Dr.G.Kavitha MD.,


Dr.B.Santhoshkumar Consultant Biochemist
SID No : 14030083 Patient ID : 1400182211
Branch : TAMBARAM

Mr. BALAMURUGAN S
Age / Sex : 41 Y 2 M / Male Collected Date : 06/08/2023 / 10:24

Ref. By : Dr. PADMA V MD (GEN MEDICINE) D.DIAB., Received Date : 06/08/2023 / 12:49
FRCP DR.PADMA'S DIABETES & MEDICAL
CLINIC
Reported Date : 06/08/2023 / 16:48

Final Test Report Page 4 of 5

Specimen Test Name Result Units Reference Range / Method


Serum Cholesterol, LDL 68.2 mg/dL Optimal : <100
Near or above optimal : 100 -
129
Borderline high : 130 - 159
High : 160 - 189
Very high : >190.
(Calculation)

Serum Cholesterol, VLDL 13.9 mg/dL Less than 30 (NCEP ATP-III)


(Calculation)

Serum Cholesterol/HDL Ratio 3.0 Castelli's Risk Index -I


Ideal : <3.5
Good: 3.5-5.0
High: >=5 (Calculation)

Serum LDL/HDL Ratio 1.6 Ratio Castelli's Risk Index -II


Ideal : <2.0
Good: 2.0-5.0
High: >=5 (Calculation)

Serum Non - HDL Cholesterol 82.1 mg/dL Adult (NCEP ATP-III)


Optimal : <130
Near or above optimal : 130-159
Borderline high : 160-189
High : 190-219
Very high : >220
(Calculation)

Verified By Dr.G.Kavitha MD.,


Dr.B.Santhoshkumar Consultant Biochemist
SID No : 14030083 Patient ID : 1400182211
Branch : TAMBARAM

Mr. BALAMURUGAN S
Age / Sex : 41 Y 2 M / Male Collected Date : 06/08/2023 / 10:24

Ref. By : Dr. PADMA V MD (GEN MEDICINE) D.DIAB., Received Date : 06/08/2023 / 12:49
FRCP DR.PADMA'S DIABETES & MEDICAL
CLINIC
Reported Date : 06/08/2023 / 16:48

Final Test Report Page 5 of 5

Specimen Test Name Result Units Reference Range / Method

Serum HDL/LDL Ratio 0.6 Ratio Optimal : >0.4


Moderate: 0.3-0.4
High : <0.3 (Calculation)

Verified By Dr.G.Kavitha MD.,


Dr.B.Santhoshkumar Consultant Biochemist

------------------------------------ End of the Report ------------------------------------

You might also like